Jazz Pharmaceuticals
JAZZ
#2129
Rank
โ‚น625.67 B
Marketcap
โ‚น10,350
Share price
2.82%
Change (1 day)
2.95%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2024 (TTM): โ‚น325.66 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น330.06 Billion. In 2023 the company made a revenue of โ‚น319.19 Billion an increase over the revenue in the year 2022 that were of โ‚น302.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น325.66 B2.03%
2023 โ‚น319.19 B5.41%
2022 โ‚น302.81 B31.48%
2021 โ‚น230.30 B33.24%
2020 โ‚น172.85 B12.13%
2019 โ‚น154.15 B16.59%
2018 โ‚น132.21 B27.93%
2017 โ‚น103.35 B2.22%
2016 โ‚น101.11 B14.85%
2015 โ‚น88.03 B18.44%
2014 โ‚น74.33 B37.92%
2013 โ‚น53.89 B67.99%
2012 โ‚น32.08 B122.75%
2011 โ‚น14.40 B84.96%
2010 โ‚น7.78 B30.66%
2009 โ‚น5.96 B83.66%
2008 โ‚น3.24 B26.62%
2007 โ‚น2.56 B29%
2006 โ‚น1.98 B105.89%
2005 โ‚น0.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น169.80 B-48.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น21.477 T 6,407.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.215 T 1,177.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น1.375 T 316.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel